The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study adopted the superiority design of multi center, randomized, double-blind, positive control drug, dose finding, using two simulation skills. The qualified subjects, according to the ratio of 1:1:1, were randomized into low dose group, high dose group and positive drug control group, and received a treatment course of 4-8 weeks, all individuals were followed up for 4 weeks after drug withdrawal.
Epistemonikos ID: e57d8a7330b1fafe98f6f3eee856b3003690ef08
First added on: May 17, 2024